Answers are grounded in this paper and cite their sources.
Chymotrypsin and subtilisin BPN‘ can be inhibited by bis(4-nitrophenyl) methylphosphonate (NMN) and bis(4-nitrophenyl) propylphosphonate (NPN) very efficiently with second-order rate constants, k i / K i, between 544 and 4300 M - 1 s - 1 at 25.0 ± 0.1 °C at the pH maxima. The second-order rate constants for the inhibition of trypsin are 26.3 ± 1.4 M - 1 s - 1 with NMN and 891 ± 14 M - 1 s - 1 with NPN at pH 8.3 and 25.0 ± 0.1 °C. A second stoichiometric equivalent 4-nitrophenol is also lost from 4-nitrophenyl alkylphosphonyl adducts of chymotrypsin but not from trypsin and subtilisin BPN‘. Elimination of 4-nitrophenol from the propylphosphonyl adduct is at a rate only about twice the rate of hydrolysis of a comparable phosphonate diester, whereas 4-nitrophenol is eliminated 270 times faster from the methylphosphonyl adduct of chymotrypsin. The activation enthalpies, in kcal/mol, for 4-nitrophenol elimination from 4-nitrophenyl alkylphosphonylchymotrypsin are 15.0 ± 1.3 for the propyl derivative, 16.4 ± 0.5 for the methyl derivative in H 2 O and 18.0 ± 0.5 in D 2 O. The activation entropies, in cal mol - 1 K - 1, are −29.7 ± 2.4 for the propyl derivative, −14.8 ± 0.5 for the methyl derivative in H 2 O, and −10.3 ± 0.3 for the methyl derivative in D 2 O. Partial solvent isotope effects for the elimination of 4-nitrophenol from 4-nitrophenyl methylphosphonylchymotrypsin give best fits to two-site proton models: These give primary isotope effects between 1.9 and 2.0 (φ 1 ⧧ = 0.52 ± 0.14 or 0.49 ± 0.07) for a proton in flight, possibly from the water attacking at phosphorus to the catalytic His, and an α-secondary effect of 1.3 (φ 2 ⧧ = 0.75 ± 0.20) or a term for solvent contribution of 1.25 (Φ = 0.80 ± 0.10). The secondary β-deuterium isotope effect on the elimination of the second 4-nitrophenol from the adduct of chymotrypsin with NMN-l 3 (l = h or d ) is 0.94 ± 0.2 possibly of hyperconjugative origin. The occurrence and mechanisms of secondary reactions in phosphonylated serine protease enzymes are markedly different from those in phosphonylated cholinesterases.
No takes yet. Share an insight, caveat, or question.
Kovach et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: